Novo Nordisk Cuts Around 9,000 Jobs as Weight-Loss Drugmaker Faces Growing Competition

MADS CLAUS RASMUSSEN / Ritzau Scanpix / AFP / Getty Images Novo Nordisk expects the job reductions will save about $1.25 billion by the end of next year. Key Takeaways Novo Nordisk said it is laying off about about 9,000 positions or 11.5% of its workforce in a "transformation" of the drugmaker's business. The maker of Ozempic and Wegovy said the cuts are part of a plan to help the company grow its diabetes and weight-loss products. Novo Nordisk expects the job reductions will save about$ 1.25 billio ...